Lactylation in the ageing nervous system: Epi-metabolic regulation, disease mechanisms, and translational challenges.
Key claim: Lysine lactylation is an emerging lactate-dependent epi-metabolic modification that links cellular metabolism to epigenetic remodeling in the ageing nervous system, with site- and context-dependent protective or pathological effects and potential as a therapeutic target.
Abstract
Lactate was long considered a waste metabolic byproduct. Currently, lactate functions as an energy substrate, signaling molecule, and epigenetic regulator in the central nervous system (CNS). Lysine lactylation (Kla), a novel lactate-dependent PTM, acts as a core epi-metabolic mediator by directly linking cellular metabolism to epigenetic remodeling. This review summarizes lactate production, shuttling, and the regulatory mechanism of lactylation (donors, writers, erasers, readers). We outline the multifaceted functions of lactylation in neurodevelopment, synaptic plasticity, and neural energy homeostasis, alongside its pathological dysregulation in major neurological disorders, with particular emphasis on ageing-related conditions. We further discuss the interplay between aberrant Kla and core ageing hallmarks, including mitochondrial dysfunction, impaired proteostasis, and inflammageing. Kla exerts site‑specific, cell‑type‑specific, and context‑dependent effects that are either protective or pathological. We also discuss therapeutic strategies targeting lactate metabolism and lactylation-modifying enzymes, analyzing the translational challenges involved. This review suggests Kla as an emerging epi-metabolic target that merits further investigation for therapeutic interventions in the ageing nervous system.
Why this matters
Lysine lactylation sits at an interface the aging field has mostly treated with separate vocabularies — lactate as a byproduct of glycolysis/OXPHOS failure, and chromatin marks as the readout of ‘epigenetic aging’ — and the review’s framing makes those the same axis in the ageing nervous system. It gives mechanism pages a concrete handle for how shifting cellular metabolism can rewrite histone and non-histone PTMs on inflammatory and neurodevelopmental loci, with site- and context-dependent direction. Writer/eraser identities, in vivo PTM dynamics, and whether modulating Kla changes any aging outcome in mammals remain unresolved.